Global Brand Lead, Navtemadlin

Ipsen•Cambridge, MA

23h•$232,500 - $320,000•Onsite

About The Position

The Global Brand Lead, Navtemadlin (GBL, Nav) is a senior commercial leader responsible for shaping and delivering the brand strategy for Navtemadlin, a Phase 3 oncology therapeutic in late-stage development. Based in the US, this role leads integrated brand planning, translates asset strategy into clear commercial priorities, and mobilizes cross-functional global, regional, and US teams to support late-stage development, launch readiness, and long-term brand value. Reporting to the Asset Lead, Navtemadlin, the GBL is especially critical where disciplined late-stage development planning, strong launch execution, and deep understanding of the US oncology market are required. The Brand Lead will bring strategic marketing expertise, strong scientific and commercial acumen, and the ability to lead through influence across Medical, Market Access, Regulatory, Insights, Finance, Supply, Legal, Business Ethics, Digital / Customer Experience, and priority affiliate teams. The ideal candidate is a strategic, externally oriented, and execution-focused leader with demonstrated late-stage development and launch experience in oncology; hematology experience is preferred.

Requirements

BA/BS (undergraduate degree) in business or life sciences is required
15+ years of experience in the pharmaceutical or biotechnology industry, including global or regional marketing, brand strategy, asset strategy and launch leadership roles.
Demonstrated late-stage development, pre-launch, and global launch experience, including in the U.S
Proven track record of developing and executing global brand strategies in collaboration with Medical, Market Access, Regulatory, Development, and Commercial functions.
Strong understanding of launch readiness, lifecycle management, evidence generation, market access across major markets, and global-to-local execution.
Demonstrated ability to lead and influence cross-functional, cross-cultural matrix teams with and without direct authority.
Fluent English is required

Nice To Haves

MBA or advanced degree is preferred.
Experience in oncology and especially in hematology is preferred.
Additional languages e.g., French or other a benefit

Responsibilities

Develop and execute the integrated brand strategy for Navtemadlin to maximize long-term asset value and patient impact.
Translate portfolio and asset objectives into clear commercial priorities, strategic initiatives, and measurable business outcomes.
Lead late-stage development commercialization planning and launch readiness activities for a Phase 3 oncology therapeutic, with a strong focus on US market requirements.
Drive lifecycle management strategies that accelerate growth, expand market opportunities, and sustain brand performance.
Lead and influence a global matrix team across Commercial, Medical, Market Access, Regulatory, Finance, Supply Chain, and other key functions.
Build alignment across global and local stakeholders to ensure effective decision-making and execution.
Leverage customer, patient, competitor, and market insights to identify opportunities, mitigate risks, and inform strategic choices.
Ensure strategies are grounded in evolving market dynamics and stakeholder needs.
Define performance metrics, monitor results, and drive course corrections to achieve business objectives.
Ensure all activities are executed in compliance with company policies and applicable regulations.